{
  "guid": "a440bb57-f7d7-493a-a17b-38dcb77a9c4a",
  "title": "Why Russia Is Exporting So Much Vaccine",
  "description": "<p>In recent years, Russia has tried to reassert its global influence in many ways, from military action in Ukraine to meddling in U.S. elections.</p><p>So when Russia developed a coronavirus vaccine, it prioritized exporting it to dozens of other countries — at the expense of its own people.</p><p>Today, we look at how Russia has put vaccine diplomacy to work. </p><p>Guest: <a href=\"https://www.nytimes.com/by/andrew-e-kramer?smid=pc-thedaily\">Andrew E. Kramer</a>, a reporter based in the Moscow bureau of The New York Times. </p><p><a href=\"https://www.nytimes.com/newsletters/signup/NTTD?smid=pc-thedaily\">Sign up here</a> to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, <a href=\"https://www.nytimes.com/newsletters/the-daily?module=inline\">subscribe to our newsletter</a>. </p><p>Background reading: </p><ul><li>The Kremlin has<a href=\"https://www.nytimes.com/2021/02/19/world/europe/russia-coronavirus-vaccine-soft-power.html?searchResultPosition=13?smid=pc-thedaily\"> scored propaganda points and bolstered several longstanding foreign policy goals</a> by offering its Sputnik V vaccine around the world. But production capacity is limited.</li><li>A microstate surrounded by Italy, San Marino feared being left behind in Europe’s inoculation campaign. Now it has jumped ahead, <a href=\"https://www.nytimes.com/2021/04/02/world/europe/italy-san-marino-sputnik-vaccine.html?smid=pc-thedaily\">with the Sputnik vaccine</a>.</li></ul><p>For more information on today’s episode, visit <a href=\"http://nytimes.com/thedaily?smid=pc-thedaily\">nytimes.com/thedaily</a>. Transcripts of each episode will be made available by the next workday. </p>\n",
  "pubDate": "Mon, 26 Apr 2021 09:50:00 +0000",
  "author": "thedaily@nytimes.com (The New York Times)",
  "link": "https://www.nytimes.com/the-daily",
  "content:encoded": "<p>In recent years, Russia has tried to reassert its global influence in many ways, from military action in Ukraine to meddling in U.S. elections.</p><p>So when Russia developed a coronavirus vaccine, it prioritized exporting it to dozens of other countries — at the expense of its own people.</p><p>Today, we look at how Russia has put vaccine diplomacy to work. </p><p>Guest: <a href=\"https://www.nytimes.com/by/andrew-e-kramer?smid=pc-thedaily\">Andrew E. Kramer</a>, a reporter based in the Moscow bureau of The New York Times. </p><p><a href=\"https://www.nytimes.com/newsletters/signup/NTTD?smid=pc-thedaily\">Sign up here</a> to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, <a href=\"https://www.nytimes.com/newsletters/the-daily?module=inline\">subscribe to our newsletter</a>. </p><p>Background reading: </p><ul><li>The Kremlin has<a href=\"https://www.nytimes.com/2021/02/19/world/europe/russia-coronavirus-vaccine-soft-power.html?searchResultPosition=13?smid=pc-thedaily\"> scored propaganda points and bolstered several longstanding foreign policy goals</a> by offering its Sputnik V vaccine around the world. But production capacity is limited.</li><li>A microstate surrounded by Italy, San Marino feared being left behind in Europe’s inoculation campaign. Now it has jumped ahead, <a href=\"https://www.nytimes.com/2021/04/02/world/europe/italy-san-marino-sputnik-vaccine.html?smid=pc-thedaily\">with the Sputnik vaccine</a>.</li></ul><p>For more information on today’s episode, visit <a href=\"http://nytimes.com/thedaily?smid=pc-thedaily\">nytimes.com/thedaily</a>. Transcripts of each episode will be made available by the next workday. </p>\n",
  "enclosure": "",
  "itunes:title": "Why Russia Is Exporting So Much Vaccine",
  "itunes:author": "The New York Times",
  "itunes:duration": "00:26:46",
  "itunes:summary": "In recent years, Russia has tried to reassert its global influence in many ways, from military action in Ukraine to meddling in U.S. elections.\n\nSo when Russia developed a coronavirus vaccine, it prioritized exporting it to dozens of other countries — at the expense of its own people.\n\nToday, we look at how Russia has put vaccine diplomacy to work. \n\nGuest: Andrew E. Kramer, a reporter based in the Moscow bureau of The New York Times.",
  "itunes:subtitle": "In recent years, Russia has tried to reassert its global influence in many ways, from military action in Ukraine to meddling in U.S. elections.\n\nSo when Russia developed a coronavirus vaccine, it prioritized exporting it to dozens of other countries — at the expense of its own people.\n\nToday, we look at how Russia has put vaccine diplomacy to work. \n\nGuest: Andrew E. Kramer, a reporter based in the Moscow bureau of The New York Times.",
  "itunes:explicit": "no",
  "itunes:episodeType": "full"
}